FI970446A0 - Urokinaasireseptorin ligandeja - Google Patents

Urokinaasireseptorin ligandeja

Info

Publication number
FI970446A0
FI970446A0 FI970446A FI970446A FI970446A0 FI 970446 A0 FI970446 A0 FI 970446A0 FI 970446 A FI970446 A FI 970446A FI 970446 A FI970446 A FI 970446A FI 970446 A0 FI970446 A0 FI 970446A0
Authority
FI
Finland
Prior art keywords
lower alkyl
halo
aryl
alkyl
cycloalkyl
Prior art date
Application number
FI970446A
Other languages
English (en)
Swedish (sv)
Other versions
FI970446A (fi
Inventor
Steve Rosenberg
Kerry L Spear
Eric J Martin
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of FI970446A0 publication Critical patent/FI970446A0/fi
Publication of FI970446A publication Critical patent/FI970446A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
FI970446A 1995-06-07 1997-02-03 Urokinaasireseptorin ligandeja FI970446A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,021 US5747458A (en) 1995-06-07 1995-06-07 Urokinase receptor ligands
PCT/US1996/009648 WO1996040747A1 (en) 1995-06-07 1996-06-06 Urokinase receptor ligands

Publications (2)

Publication Number Publication Date
FI970446A0 true FI970446A0 (fi) 1997-02-03
FI970446A FI970446A (fi) 1997-03-26

Family

ID=23926620

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970446A FI970446A (fi) 1995-06-07 1997-02-03 Urokinaasireseptorin ligandeja

Country Status (14)

Country Link
US (2) US5747458A (fi)
EP (1) EP0777680B1 (fi)
JP (1) JPH10503784A (fi)
AT (1) ATE214711T1 (fi)
AU (1) AU6164096A (fi)
BR (1) BR9606429A (fi)
CA (1) CA2196334A1 (fi)
DE (1) DE69619940T2 (fi)
FI (1) FI970446A (fi)
HU (1) HUP9702220A3 (fi)
IL (1) IL120101A0 (fi)
MX (1) MX9700888A (fi)
NO (1) NO970513D0 (fi)
WO (1) WO1996040747A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
EP1012147B1 (en) * 1997-07-31 2005-11-02 F. Hoffmann-La Roche Ag O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
WO1999055688A1 (en) * 1998-04-27 1999-11-04 Warner-Lambert Company Substituted diarylalkyl amides as calcium channel antagonists
US6228985B1 (en) 1998-05-21 2001-05-08 Schering Corporation Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents
ES2169690B1 (es) * 2000-10-06 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de proteger a neuronas contra agresiones excitotoxicas, y composiciones que los contienen.
ES2169691B1 (es) * 2000-10-11 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de bloquear la respuesta a sustancias quimicas, estimulos termicos o mediadores de la inflamacion de receptores neuronales, y composiciones que los contienen.
AU2004230207A1 (en) * 2003-04-15 2004-10-28 Merck Patent Gmbh Identification of N-alkylglycine trimers for induction of apoptosis
PT2611775E (pt) 2010-08-31 2016-06-07 Consejo Superior De Investig Científicas Agonistas dos recetores de neurotrofina e sua utilização como medicamentos
WO2012073375A1 (ja) 2010-12-03 2012-06-07 富士通株式会社 新規化合物、並びに、キネシンスピンドルタンパク質阻害剤及びその応用
IT202100023357A1 (it) 2021-09-09 2023-03-09 Cheirontech S R L Peptidi con attività anti-angiogenica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138854B1 (en) * 1983-03-08 1992-11-04 Chiron Mimotopes Pty. Ltd. Antigenically active amino acid sequences
CA1255586A (en) * 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
IE66205B1 (en) * 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
WO1994006451A1 (en) * 1992-09-24 1994-03-31 Chiron Corporation Synthesis of n-substituted oligomers
US5536853A (en) * 1994-04-11 1996-07-16 Chiron Corporation Opiate receptor ligands
ZA953361B (en) * 1994-04-26 1996-01-12 Selectide Corp Factor Xa inhibitors

Also Published As

Publication number Publication date
MX9700888A (es) 1997-04-30
NO970513L (no) 1997-02-05
JPH10503784A (ja) 1998-04-07
US6121240A (en) 2000-09-19
AU6164096A (en) 1996-12-30
BR9606429A (pt) 1997-09-02
EP0777680A1 (en) 1997-06-11
DE69619940D1 (de) 2002-04-25
US5747458A (en) 1998-05-05
NO970513D0 (no) 1997-02-05
WO1996040747A1 (en) 1996-12-19
ATE214711T1 (de) 2002-04-15
DE69619940T2 (de) 2002-12-19
EP0777680B1 (en) 2002-03-20
HUP9702220A2 (hu) 1998-05-28
CA2196334A1 (en) 1996-12-19
HUP9702220A3 (en) 1998-06-29
IL120101A0 (en) 1997-04-15
FI970446A (fi) 1997-03-26

Similar Documents

Publication Publication Date Title
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
NO950297L (no) Prolinamidderivater
ATE255564T1 (de) Imidazolderivat
ATE152719T1 (de) Chinolylbenzofuran derivate als leukotrien- antagonisten
DE3853577D1 (de) Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen.
DE60137540D1 (de) Methoden zur behandlung von angstzuständen
FI970446A0 (fi) Urokinaasireseptorin ligandeja
FI952424A0 (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
BR9610876A (pt) Inibidores de protease de guanidino
ATE144530T1 (de) Glutathionderivat
ES2037613A1 (es) Procedimiento de obtencion de nuevos derivados dipeptidicos.
ATE47135T1 (de) Antikonvulsive mittel.
SE9704770D0 (sv) New use
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
JPS57126461A (en) Novel guanidino compound and its preparation
AP2000002009A0 (en) Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity.
ATE223406T1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
WO2002088091A3 (en) Inhibitors of human rhinovirus 2a cysteine protease
EA199800148A1 (ru) 1-дезокси-1-n-(метил-(2-акридон-9-он-10-ил-ацетат)-аммоний-d-глюцитола, обладающий пролонгированной интерфероногенной активностью в отношении всех типов интерферона
ATE128978T1 (de) N,n',n'-trisubstituierte 5-bisaminomethylen-1,3- dioxan-4,6-dione als acyl-coa: cholesterol- acyltransferasehemmer.
HUP9903260A2 (hu) Antibiotikus hatású 2,4-diamino-pirimidin-származékok, előállításuk és alkalmazások